US EditionWhat’s a fair price for a drug that’s never developed? - Elizabethton Star
Summary by Elizabethton Star
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
What’s a fair price for a drug that’s never developed? - Elizabethton Star
By John Stanford This month, the Centers for Medicare & Medicaid Services will begin meeting with patients who use the 15 drugs it selected for the second round of Medicare price “negotiations” — including weight-loss treatment Wegovy. CMS will use these discussions to inform the lower prices it will set for the medicines. What CMS won’t address is the growing list of drugs that will never be developed as a result of government price-setting. It…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
